LucidTrends Analysis: Immunology competitors (US) - April 10th 2025
🔎 Search Trends Reveal Immunology Leaders: Rinvoq, Skyrizi & Sotyktu…
LucidTrends Analysis: Hemophilia B (US) - April 1st 2025
🔬 Hemophilia B Treatment Trends: Key Insights & Market Shifts 🩸 In this…
LucidTrends Analysis: Major Depressive Disorder (EU) - March 21st 2025
🔬 What’s Shaping the Future of MDD Treatment Searches Across Europe? Dive into…
Cell and Gene Therapy Clinical Trials 2025 Edition
Introduction Cell and gene therapy (CGT) represents a groundbreaking frontier…
AI-Powered Medical Affairs: Enhancing value, engagement, and insights
The pharmaceutical sector is witnessing a transformative shift fueled by the…
Unveiling the Financial Ties: HCPs, PAOs and Pharmaceutical Funding
The entanglement of financial relationships among healthcare professionals…
New antibiotics on the way: How pharma can tackle the Antimicrobial Resistance crisis
The overuse and misuse of antimicrobials in humans and animals have escalated…
How Education can serve as a catalyst for wider Biosimilar Adoption.
Even two decades after their introduction, the global adoption rate of…
Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond
The anticipated expiration of exclusivity rights for major biologics in 2022…
The Next Frontier: Pharma and Longevity
From The Epic of Gilgamesh, the earliest surviving book, to the controversial…
mRNA personalized Cancer Vaccines: BioNTech and Moderna Race to the Finish Line
With the emergence of immunotherapy for oncology, cancer vaccines are cropping…
Cell and Gene Therapy Clinical Trials – 2024 Edition
Gene therapy clinical trials promise transformative breakthroughs in treating…